The Effect of Ketorolac on Posterior Minimally Invasive Transforaminal Lumbar Interbody Fusion: an interim analysis from a randomized, double-blinded, placebo-controlled trial

Posted: September 7, 2021 at 8:29 pm   /   by   /   comments (0)